Skip to main content
. 2016 Feb 19;7(12):14940–14950. doi: 10.18632/oncotarget.7496

Figure 3. Targeted silencing of ABCB5 did not significantly suppress tumor growth.

Figure 3

A. Silencing of ABCB5 expression in B16F10 tumor following i.p. injection of VNP-shABCB5. Data are presented as mean ± SD. **P < 0.01 for VNP-scrambled versus VNP-shABCB5. B. Tumor growth curves. The tumor-bearing mice were injected i.p. with PBS, VNP-scrambled and VNP-shABCB5 (n = 8, each group). Tumor volumes among different groups were compared. Data are presented as mean ± SD. *P < 0.05 for PBS versus VNP-scrambled and VNP-shABCB5. C. Kaplan-Meier survival curves of the mice bearing B16F10 melanomas. Data were analyzed by the log-rank test. * for P < 0.05 for VNP-shABCB5 versus VNP-scrambled.